Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Degludec/Liraglutide vs Basal Bolus in Diabetic Inpatients
NCT05360537Phase 4Completed
- Sponsor
- University of Palermo
- Start
- Apr 2021
- Primary completion
- Dec 2021
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin degludec + liraglutide in type 2 diabetes mellitus (T2DM), sponsored by University of Palermo. Started Apr 2021; status: completed.
02
Drugs
insulin degludec + liraglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05360537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05360537.